Microdosing, Tested for 28 Days

This video from the YouTube channel StoneAgeMan surveys psilocybin microdosing, taking roughly 5 to 10 percent of a full psychoactive dose on a regular schedule, then documents the creator's own 28-day self-experiment with it. Most of what it covers rests on self-report survey research rather than controlled trials, so treat this as an overview of common claims plus one person's anecdotal account, not as clinical evidence.

Context: mushrooms, doses, and the research backdrop

The video opens with fly agaric (Amanita muscaria), called the oldest intoxicant on record, and psilocybin-containing Psilocybe mushrooms, long used in Indigenous ceremony in Mexico and elsewhere. A "heroic dose" is put at around 5 grams of dried mushroom. It cites the well-known Johns Hopkins trial, where a single high-dose psilocybin session produced large, rapid, and lasting drops in depression and anxiety, the backdrop against which microdosing, far smaller and more frequent, gets framed as a gentler alternative.

What microdosing means, and why the evidence is thin

Microdosing is roughly 5 to 10 percent of a full dose, often taken two to four times a week for weeks or months, a term credited to psychologist Dr. James Fadiman. Legal restrictions limit lab-based studies, so most of what is known comes from self-report surveys: reduced anxiety and depression, milder migraines, easier learning and focus, eased PMS symptoms, less trauma-related triggering, and changes in libido and work quality. The video also notes a recent controlled study that found no effect, and quotes Fadiman arguing its mostly healthy, low-symptom sample may have masked a real effect. See microdosing psilocybin research for more on where this evidence stands.

Possible mechanisms, and one therapist's caution

Explanations raised include a placebo response (framed as the body's own capacity to improve when cued to), a slow systemic effect like a vitamin, a possible mitochondrial role, and increased neuroplasticity, better documented at higher doses. None are settled. Psychedelic psychotherapist Irene Dubin says clients describe mood and pain improvements, but stresses doses should stay below any noticeable threshold. Some people also describe eating better, exercising more, and using less alcohol or other substances alongside microdosing.

Macro versus micro, and one person's 28-day experiment

Not everyone in the video agrees microdosing is the better tool: a retreat facilitator, called Trad, argues a full macro dose is what lets someone work through what is troubling them, since a microdose might just numb it for the day. The creator ran his own 28-day self-experiment, a single, self-reported account, alongside friends. He reported feeling better overall, tackling tasks he had put off for a year, and finding chores more enjoyable, with less impatience and quieter negative self-talk. On higher-dose days he noticed a mild dip in complex problem-solving, comparable to half a glass of alcohol, enough to make him wary of driving. See psychedelic safety and harm reduction for general guidance on this kind of impairment.

Key takeaways

• ●Microdosing means roughly 5 to 10 percent of a full psilocybin dose, taken several times a week for weeks or months, aiming for subtle rather than altered effects.
• ●Most claims rest on self-report survey data popularized by psychologist Dr. James Fadiman, not controlled clinical trials.
• ●The creator's own 28-day self-experiment is a single, anecdotal account, not evidence of what microdosing does for people generally.
• ●He reported better mood, more motivation for tedious tasks, and a mild, alcohol-like dip in problem-solving on higher-dose days.
• ●A more recent controlled study found no benefit, though its mostly healthy, low-symptom sample may have masked a real effect.
• ●Proposed mechanisms include placebo response, a cumulative systemic effect, mitochondrial involvement, and increased neuroplasticity, none confirmed.
• ●A retreat facilitator interviewed argues a full macro dose, not a microdose, is what allows someone to work through underlying issues.